Abstract
Staphylococcus aureus (S. aureus) is an important foodborne and environmental pathogen that can produce toxins in foods and cause infections in soft tissues. S. aureus that have developed resistance to the conventional antimicrobials are commonly called Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant S. aureus (VRSA). Their prevalence is believed to be due to the widespread use of antibiotics. Therefore, natural antimicrobials are in urgent demand as alternatives to conventional antibiotics to treat S. aureus infections. In this review, natural antimicrobials from plant, animal and microbiological origins are discussed, including their mode of action and mechanisms of bacterial resistance, major components, chemical structure, effectiveness, synergistic effects and future prospects.
Keywords: Antibiotic resistance, MRSA, Natural antimicrobials, S. aureus, toxins, cause infections in soft tissues., Methicillin-Resistant, Vancomycin-Resistant, life-threatening infections, staphylococcal gastroenteritis, staphylococcal food poisoning, abdominal cramping, nausea, muscle cramping, endocarditis
Current Pharmaceutical Biotechnology
Title: Use of Natural Antimicrobials from a Food Safety Perspective for Control of Staphylococcus aureus
Volume: 12 Issue: 8
Author(s): Min Li, Arunachalam Muthaiyan, Corliss A. O'Bryan, John E. Gustafson, Y. Li, Philip G. Crandall and Steven C. Ricke
Affiliation:
Keywords: Antibiotic resistance, MRSA, Natural antimicrobials, S. aureus, toxins, cause infections in soft tissues., Methicillin-Resistant, Vancomycin-Resistant, life-threatening infections, staphylococcal gastroenteritis, staphylococcal food poisoning, abdominal cramping, nausea, muscle cramping, endocarditis
Abstract: Staphylococcus aureus (S. aureus) is an important foodborne and environmental pathogen that can produce toxins in foods and cause infections in soft tissues. S. aureus that have developed resistance to the conventional antimicrobials are commonly called Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant S. aureus (VRSA). Their prevalence is believed to be due to the widespread use of antibiotics. Therefore, natural antimicrobials are in urgent demand as alternatives to conventional antibiotics to treat S. aureus infections. In this review, natural antimicrobials from plant, animal and microbiological origins are discussed, including their mode of action and mechanisms of bacterial resistance, major components, chemical structure, effectiveness, synergistic effects and future prospects.
Export Options
About this article
Cite this article as:
Li Min, Muthaiyan Arunachalam, A. O'Bryan Corliss, E. Gustafson John, Li Y., G. Crandall Philip and C. Ricke Steven, Use of Natural Antimicrobials from a Food Safety Perspective for Control of Staphylococcus aureus, Current Pharmaceutical Biotechnology 2011; 12(8) . https://dx.doi.org/10.2174/138920111796117283
DOI https://dx.doi.org/10.2174/138920111796117283 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Strategies for Antimicrobial Drug Delivery to Biofilm
Current Pharmaceutical Design Therapeutic Utilities of Pediatric Cardiac Catheterization
Current Cardiology Reviews The Role of Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Drug Development for Ischemic Stroke: From Laboratory to Clinics
Current Vascular Pharmacology Kawasaki Disease and Its Treatment – An Update
Current Rheumatology Reviews Phytochemical Analysis and Antibacterial Action of Indian Traditional Medicinal Plants
Anti-Infective Agents Hybrid Viral Vectors for Vaccine and Antibody Production in Plants
Current Pharmaceutical Design Waste Material of Propolis as a Film Forming Agent Intended to Modify the Metronidazole Release: Preparation and Characterization
Current Drug Delivery Effects of HIV-1 Entry Inhibitors in Combination
Current Pharmaceutical Design Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients
Current Pharmaceutical Design Update on Childhood Brucellosis
Recent Patents on Anti-Infective Drug Discovery New Treatments for Emerging Cystic Fibrosis Pathogens other than Pseudomonas
Current Pharmaceutical Design Role of Old Antibiotics in Multidrug Resistant Bacterial Infections
Current Drug Targets Coronary Artery Bypass Graft in HIV-Infected Patients: A Multicenter Case Control Study
Current HIV Research Molecular Imaging of Vascular Thrombosis
Current Molecular Imaging (Discontinued) Prevalence of Dilated Cardiomyopathy in HIV-Infected African Patients Not Receiving HAART: A Multicenter, Observational, Prospective, Cohort Study in Rwanda
Current HIV Research Effect of Silver Nanoparticles (AgNPs) on <i>Candida albicans, Candida dubliniensis</i> and <i>Candida guilliermondii</i>
Current Drug Therapy Levosimendan: A New Inodilatory Drug for the Treatment of Decompensated Heart Failure
Current Pharmaceutical Design Concurrent Methicillin-Resistant <i>Staphylococcus aureus Septicemia</i> and Thyroid Abscess in a Young Male with Dengue
Infectious Disorders - Drug Targets A Brief Overview of Antimicrobial Peptides Containing Unnatural Amino Acids and Ligand-Based Approaches for Peptide Ligands
Current Topics in Medicinal Chemistry The Role of Hypoxia and Platelets in Air Travel-Related Venous Thromboembolism
Current Pharmaceutical Design